2024 Medical Device Investment Data: A Brighter Exit Path, A Challenging Funding Road

Avio's friends at Nocturnal wrote a great post on medtech funding in 2024 and what that could mean for 2025.

Avio's take?

• The pickup in M&A and (brief) return of IPOs are positives.

• Challenges with NIH funding, the FDA, and economic uncertainty are negatives.

  
  

But you knew that already!

What to do? Spend small money on good plans so you don't spend big money on bad projects.

Every dollar matters even more. While it can seem "expensive," spending money on market validation, ensuring your regulatory strategy fits the world today, and your risks are well articulated and managed is an easy way to save money.

What are we seeing to start 2025? Investment activity has been steady. Its always hard to raise money but.

Structured deals continue - more startups we speak with are sharing they have deals with a strategic for a pre-determined amount. Gives them (and their investors) certainty. Caps total value but lowers risk.

You can read the full post here: 2024 Medical Device Investment Data: A Brighter Exit Path, A Challenging Funding Road - Nocturnal